Memantine, a cheaply available drug used for decades to treat Alzheimer's, may help prevent sickle cell crises, especially in ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...

Memantine, a drug approved for Alzheimer’s disease, was associated with significant improvement in social functioning in some children and adolescents with autism spectrum disorder (ASD) without ...

Elevated pregenual anterior cingulate cortex levels were associated with a favorable treatment response. HealthDay News — Memantine improves social impairments in youth with autism spectrum disorder ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe AD as ...

“This study suggests that there is no protective (or harmful) association of memantine [a second-line drug for dementia] or donepezil [a first-line drug] with the risk of developing age-related ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...